Whalerock Point Partners, LLC Amgen Inc Transaction History

Whalerock Point Partners, LLC

$372 Million
Q2 2024

A detailed history of Whalerock Point Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Whalerock Point Partners, LLC holds 2,047 shares of AMGN stock, worth $648,714. This represents 0.17% of its overall portfolio holdings.

Number of Shares

2,047

Previous 2,047 -0.0%

Holding current value

$648,714

Previous $582,000 9.79%

% of portfolio

0.17%

Previous 0.17%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $26,887 - $32,456	-100 Reduced 4.66%	2,047 $582,000
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $51,140 - $57,691	-200 Reduced 8.52%	2,147 $618,000
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $14,998 - $17,735	70 Added 3.07%	2,347 $521,000
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $10,535 - $13,386	46 Added 2.06%	2,277 $598,000
Q3 2022 Nov 16, 2022	BUY	$224.46 - $253.15 $387,866 - $437,443	1,728 Added 343.54%	2,231 $503,000
Q3 2022 Nov 15, 2022	SELL	$224.46 - $253.15 $387,866 - $437,443	-1,728 Reduced 77.45%	503 $503 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $115,355 - $128,370	-500 Reduced 18.31%	2,231 $543,000
Q4 2021 Feb 15, 2022	SELL	$198.88 - $227.6 $75,574 - $86,488	-380 Reduced 12.21%	2,731 $614,000
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $10,613 - $12,435	-50 Reduced 1.58%	3,111 $662,000
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $510,224 - $607,585	2,358 Added 293.65%	3,161 $727,000
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $560,813 - $623,670	-2,390 Reduced 74.85%	803 $204,000
Q2 2020 Aug 11, 2020	SELL	$197.81 - $242.74 $73,189 - $89,813	-370 Reduced 10.38%	3,193 $753,000
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $183,151 - $242,908	-1,005 Reduced 22.0%	3,563 $722,000
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $189 - $243	-1 Reduced 0.02%	4,568 $1.1 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $32,732 - $39,220	-188 Reduced 3.95%	4,569 $884,000
Q2 2019 Aug 09, 2019	SELL	$166.7 - $195.41 $40,841 - $47,875	-245 Reduced 4.9%	4,757 $877,000
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $450,185 - $507,457	2,489 Added 99.04%	5,002 $950,000
Q4 2018 Mar 04, 2019	SELL	$178.4 - $208.25 $213,723 - $249,483	-1,198 Reduced 32.28%	2,513 $489,000
Q3 2018 Mar 04, 2019	SELL	$185.29 - $208.89 $6,855 - $7,728	-37 Reduced 0.99%	3,711 $769,000
Q2 2018 Mar 04, 2019	SELL	$166.05 - $186.51 $1.25 Million - $1.4 Million	-7,500 Reduced 66.68%	3,748 $692,000
Q1 2018 Apr 05, 2018	BUY	$169.43 - $198.0 $350,211 - $409,266	2,067 Added 22.51%	11,248 $1.92 Million
Q4 2017 Jan 16, 2018	BUY	$168.79 - $188.59 $287,618 - $321,357	1,704 Added 22.79%	9,181 $1.6 Million
Q3 2017 Oct 31, 2017	BUY	$167.29 - $191.0 $1.25 Million - $1.43 Million	7,477	7,477 $1.39 Million

Others Institutions Holding AMGN

# of Institutions

3,087

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.13M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $170B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Whalerock Point Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Whalerock Point Partners, LLC with notifications on news.

Account

Whalerock Point Partners, LLC Amgen Inc Transaction History